Amgen Inc. (NASDAQ:AMGN) is one of the 11 stocks Jim Cramer put under the microscope recently. Cramer highlighted Wall Street ...

Eagles star Dallas Goedert opens up about a lifelong struggle that he has become a proud spokesperson for with his latest ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

Despite investing tens of billions of dollars into OpenAI, Microsoft is still, apparently, competing with its business ...

Guggenheim analyst Vamil Divan maintained a Hold rating on Amgen (AMGN – Research Report) yesterday and set a price target of $288.00. The company’s shares closed yesterday at ...

Evercore ISI analyst Umer Raffat maintained a Buy rating on Amgen (AMGN – Research Report) yesterday. The company’s shares closed yesterday at $277.49. Confident Investing Sta ...

In a Phase II trial, Amgen’s investigational therapy MariTide (maridebart cafraglutide) delivered significant, sustained ...

A new experimental drug meant to be taken just once a month could lead to “substantial weight reduction” within a year and ...